Top Markets
#1 Siren Siren +33.55%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.97%
#3 Ribbita by Virtuals Ribbita by Virtuals +18.33%
#4 Wiki Cat Wiki Cat +17.15%
#5 PulseChain PulseChain +16.92%
#6 Velvet Velvet +16.44%
#7 Cysic Cysic +16.42%
#8 Bitway Bitway +16.08%
#9 KUB Coin KUB Coin +15.73%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.35%
Coin of the day
Siren Siren
設定
言語
日本
通貨
USD
テーマ
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
株式のランク #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
株価
$0.39
時価総額
$13.79M
変化（1日）
-13.53%
変化（1年）
-68.80%
国
IL
取引 NeuroSense Therapeutics Ltd. (NRSN)

カテゴリー

Healthcare
NeuroSense Therapeutics Ltd.（NRSN）の配当履歴
NeuroSense Therapeutics Ltd.（証券コード：NRSN）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのNeuroSense Therapeutics Ltd.（NRSN）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
年 配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
29.00%
BE